ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Attention Deficit Hyperactivity Disorder (ADHD) Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-14N9172
Home | Market Reports
Global Attention Deficit Hyperactivity Disorder ADHD Market Size Status and Forecast 2022
BUY CHAPTERS

Global Attention Deficit Hyperactivity Disorder (ADHD) Market Research Report 2026

Code: QYRE-Auto-14N9172
Report
2026-04-10
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
NEOS Therapeutics
Mallinckrodt plc
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Zhengdafenhai
Highland Therapeutics
Jubilant Life Sciences
Medice Arzneimittel Putter
Lannett
Johnson & Johnson

Attention Deficit Hyperactivity Disorder (ADHD) Market Size

The global Attention Deficit Hyperactivity Disorder (ADHD) market was valued at US$ 13920 million in 2025 and is anticipated to reach US$ 19370 million by 2032, at a CAGR of 4.9% from 2026 to 2032.

Attention Deficit Hyperactivity Disorder (ADHD) Market

Attention Deficit Hyperactivity Disorder (ADHD) Market

Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.
The ADHD market is expanding rapidly due to rising global awareness and increasing diagnosis rates, especially in children and young adults. Improved understanding of mental health conditions among healthcare providers, educators, and parents has contributed to earlier identification and more proactive treatment approaches. Government-supported initiatives, mental health screenings in schools, and expanded insurance coverage have made ADHD treatment more accessible in both developed and developing regions. Furthermore, advancements in pharmacological research have led to the availability of more effective, long-acting, and better-tolerated medications, expanding the range of treatment options. The rise of digital health platforms, including telemedicine and mobile apps for symptom monitoring, has also made ADHD management more convenient and efficient. Growing adult ADHD diagnosis, driven by increased public discussion and reduced stigma, is further contributing to market growth.
Despite the increasing demand, the ADHD market faces several significant challenges. One of the main concerns is the potential overdiagnosis or misdiagnosis of ADHD, particularly in children, leading to inappropriate or excessive use of medications. Differentiating ADHD from other behavioral or psychological disorders like anxiety, autism, or learning disabilities remains complex, often requiring multidisciplinary assessments. Medication side effects, such as insomnia, appetite suppression, and cardiovascular concerns, can lead to treatment non-compliance or discontinuation. There are also regulatory barriers around stimulant drug prescriptions due to their potential for abuse and dependency. Additionally, disparities in healthcare infrastructure and limited access to trained mental health professionals in low-income and rural areas hinder timely diagnosis and treatment. Cultural stigma around psychiatric disorders still discourages many individuals and families from seeking medical help, especially in emerging markets.
This report delivers a comprehensive overview of the global Attention Deficit Hyperactivity Disorder (ADHD) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Attention Deficit Hyperactivity Disorder (ADHD). The Attention Deficit Hyperactivity Disorder (ADHD) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Attention Deficit Hyperactivity Disorder (ADHD) market comprehensively. Regional market sizes by Type, by Distribution Channel, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Attention Deficit Hyperactivity Disorder (ADHD) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Distribution Channel, and by region.
Market Segmentation

Scope of Attention Deficit Hyperactivity Disorder (ADHD) Market Report

Report Metric Details
Report Name Attention Deficit Hyperactivity Disorder (ADHD) Market
Accounted market size in 2025 US$ 13920 million
Forecasted market size in 2032 US$ 19370 million
CAGR 4.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Stimulant
  • Non-stimulant
Segment by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma, Zhengdafenhai, Highland Therapeutics, Jubilant Life Sciences, Medice Arzneimittel Putter, Lannett
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Distribution Channel, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Attention Deficit Hyperactivity Disorder (ADHD) companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Distribution Channel, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Attention Deficit Hyperactivity Disorder (ADHD) Market growing?

Ans: The Attention Deficit Hyperactivity Disorder (ADHD) Market witnessing a CAGR of 4.9% during the forecast period 2026-2032.

What is the Attention Deficit Hyperactivity Disorder (ADHD) Market size in 2032?

Ans: The Attention Deficit Hyperactivity Disorder (ADHD) Market size in 2032 will be US$ 19370 million.

Who are the main players in the Attention Deficit Hyperactivity Disorder (ADHD) Market report?

Ans: The main players in the Attention Deficit Hyperactivity Disorder (ADHD) Market are Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma, Zhengdafenhai, Highland Therapeutics, Jubilant Life Sciences, Medice Arzneimittel Putter, Lannett

What are the Type segmentation covered in the Attention Deficit Hyperactivity Disorder (ADHD) Market report?

Ans: The Types covered in the Attention Deficit Hyperactivity Disorder (ADHD) Market report are Stimulant, Non-stimulant

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 Market by Distribution Channel
1.3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Growth by Distribution Channel: 2021 vs 2025 vs 2032
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Perspective (2021–2032)
2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Growth Trends by Region
2.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Region (2021–2026)
2.2.3 Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Region (2027–2032)
2.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Dynamics
2.3.1 Attention Deficit Hyperactivity Disorder (ADHD) Industry Trends
2.3.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
2.3.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges
2.3.4 Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue
3.1.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue (2021–2026)
3.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Players (2021–2026)
3.2 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Attention Deficit Hyperactivity Disorder (ADHD) Revenue
3.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Concentration Ratio
3.4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit Hyperactivity Disorder (ADHD) Revenue in 2025
3.5 Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD) Head Offices and Areas Served
3.6 Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD), Products and Applications
3.7 Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Attention Deficit Hyperactivity Disorder (ADHD) Breakdown Data by Type
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Type (2021–2026)
4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (2027–2032)
5 Attention Deficit Hyperactivity Disorder (ADHD) Breakdown Data by Distribution Channel
5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Distribution Channel (2021–2026)
5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Distribution Channel (2027–2032)
6 North America
6.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2021–2032)
6.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2021–2026)
6.4 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2021–2032)
7.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2021–2026)
7.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2021–2032)
8.2 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2021–2026)
8.4 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2021–2032)
9.2 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2021–2026)
9.4 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2021–2032)
10.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2021–2026)
10.4 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.1.4 Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.1.5 Takeda Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.2.4 Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.3.4 Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.3.5 Novartis Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.4.4 Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.4.5 Eli Lilly Recent Development
11.5 Tris Pharma
11.5.1 Tris Pharma Company Details
11.5.2 Tris Pharma Business Overview
11.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.5.4 Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.5.5 Tris Pharma Recent Development
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Details
11.6.2 Neos Therapeutics Business Overview
11.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.6.4 Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.6.5 Neos Therapeutics Recent Development
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Details
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.7.4 Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.7.5 Mallinckrodt Recent Development
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Details
11.8.2 Amneal Pharmaceuticals Business Overview
11.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.8.4 Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.8.5 Amneal Pharmaceuticals Recent Development
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Details
11.9.2 Noven Pharmaceuticals Business Overview
11.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.9.4 Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.9.5 Noven Pharmaceuticals Recent Development
11.10 Purdue Parma
11.10.1 Purdue Parma Company Details
11.10.2 Purdue Parma Business Overview
11.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.10.4 Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.10.5 Purdue Parma Recent Development
11.11 Zhengdafenhai
11.11.1 Zhengdafenhai Company Details
11.11.2 Zhengdafenhai Business Overview
11.11.3 Zhengdafenhai Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.11.4 Zhengdafenhai Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.11.5 Zhengdafenhai Recent Development
11.12 Highland Therapeutics
11.12.1 Highland Therapeutics Company Details
11.12.2 Highland Therapeutics Business Overview
11.12.3 Highland Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.12.4 Highland Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.12.5 Highland Therapeutics Recent Development
11.13 Jubilant Life Sciences
11.13.1 Jubilant Life Sciences Company Details
11.13.2 Jubilant Life Sciences Business Overview
11.13.3 Jubilant Life Sciences Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.13.4 Jubilant Life Sciences Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.13.5 Jubilant Life Sciences Recent Development
11.14 Medice Arzneimittel Putter
11.14.1 Medice Arzneimittel Putter Company Details
11.14.2 Medice Arzneimittel Putter Business Overview
11.14.3 Medice Arzneimittel Putter Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.14.4 Medice Arzneimittel Putter Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.14.5 Medice Arzneimittel Putter Recent Development
11.15 Lannett
11.15.1 Lannett Company Details
11.15.2 Lannett Business Overview
11.15.3 Lannett Attention Deficit Hyperactivity Disorder (ADHD) Introduction
11.15.4 Lannett Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
11.15.5 Lannett Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
NEOS Therapeutics
Mallinckrodt plc
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Zhengdafenhai
Highland Therapeutics
Jubilant Life Sciences
Medice Arzneimittel Putter
Lannett
Johnson & Johnson
List of Tables
 Table 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Stimulant
 Table 3. Key Players of Non-stimulant
 Table 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth by Distribution Channel (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2021–2026)
 Table 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2027–2032)
 Table 10. Attention Deficit Hyperactivity Disorder (ADHD) Market Trends
 Table 11. Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
 Table 12. Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges
 Table 13. Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints
 Table 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Players (2021–2026)
 Table 16. Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Attention Deficit Hyperactivity Disorder (ADHD) Revenue, 2025
 Table 17. Ranking of Global Top Attention Deficit Hyperactivity Disorder (ADHD) Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD), Headquarters and Area Served
 Table 20. Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD), Products and Applications
 Table 21. Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD), Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2021–2026)
 Table 25. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2027–2032)
 Table 27. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (US$ Million), 2021–2026
 Table 28. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2021–2026)
 Table 29. Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Distribution Channel (US$ Million), 2027–2032
 Table 30. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2027–2032)
 Table 31. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (US$ Million), 2027–2032
 Table 46. Takeda Company Details
 Table 47. Takeda Business Overview
 Table 48. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 49. Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 50. Takeda Recent Development
 Table 51. Johnson & Johnson Company Details
 Table 52. Johnson & Johnson Business Overview
 Table 53. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 54. Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 55. Johnson & Johnson Recent Development
 Table 56. Novartis Company Details
 Table 57. Novartis Business Overview
 Table 58. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 59. Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 60. Novartis Recent Development
 Table 61. Eli Lilly Company Details
 Table 62. Eli Lilly Business Overview
 Table 63. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 64. Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 65. Eli Lilly Recent Development
 Table 66. Tris Pharma Company Details
 Table 67. Tris Pharma Business Overview
 Table 68. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 69. Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 70. Tris Pharma Recent Development
 Table 71. Neos Therapeutics Company Details
 Table 72. Neos Therapeutics Business Overview
 Table 73. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 74. Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 75. Neos Therapeutics Recent Development
 Table 76. Mallinckrodt Company Details
 Table 77. Mallinckrodt Business Overview
 Table 78. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 79. Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 80. Mallinckrodt Recent Development
 Table 81. Amneal Pharmaceuticals Company Details
 Table 82. Amneal Pharmaceuticals Business Overview
 Table 83. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 84. Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 85. Amneal Pharmaceuticals Recent Development
 Table 86. Noven Pharmaceuticals Company Details
 Table 87. Noven Pharmaceuticals Business Overview
 Table 88. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 89. Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 90. Noven Pharmaceuticals Recent Development
 Table 91. Purdue Parma Company Details
 Table 92. Purdue Parma Business Overview
 Table 93. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 94. Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 95. Purdue Parma Recent Development
 Table 96. Zhengdafenhai Company Details
 Table 97. Zhengdafenhai Business Overview
 Table 98. Zhengdafenhai Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 99. Zhengdafenhai Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 100. Zhengdafenhai Recent Development
 Table 101. Highland Therapeutics Company Details
 Table 102. Highland Therapeutics Business Overview
 Table 103. Highland Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 104. Highland Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 105. Highland Therapeutics Recent Development
 Table 106. Jubilant Life Sciences Company Details
 Table 107. Jubilant Life Sciences Business Overview
 Table 108. Jubilant Life Sciences Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 109. Jubilant Life Sciences Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 110. Jubilant Life Sciences Recent Development
 Table 111. Medice Arzneimittel Putter Company Details
 Table 112. Medice Arzneimittel Putter Business Overview
 Table 113. Medice Arzneimittel Putter Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 114. Medice Arzneimittel Putter Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 115. Medice Arzneimittel Putter Recent Development
 Table 116. Lannett Company Details
 Table 117. Lannett Business Overview
 Table 118. Lannett Attention Deficit Hyperactivity Disorder (ADHD) Product
 Table 119. Lannett Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (US$ Million), 2021–2026
 Table 120. Lannett Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Attention Deficit Hyperactivity Disorder (ADHD) Picture
 Figure 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Type: 2025 vs 2032
 Figure 4. Stimulant Features
 Figure 5. Non-stimulant Features
 Figure 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (US$ Million), 2021–2032
 Figure 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Distribution Channel: 2025 vs 2032
 Figure 8. Hospital Pharmacy Case Studies
 Figure 9. Retail Pharmacy Case Studies
 Figure 10. Attention Deficit Hyperactivity Disorder (ADHD) Report Years Considered
 Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region: 2025 vs 2032
 Figure 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Players in 2025
 Figure 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 16. The Top 10 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Revenue in 2025
 Figure 17. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 18. North America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2021–2032)
 Figure 19. United States Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. Canada Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2021–2032)
 Figure 23. Germany Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. France Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. U.K. Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Italy Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Russia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Ireland Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Region (2021–2032)
 Figure 31. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. India Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Australia & New Zealand Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2021–2032)
 Figure 39. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Country (2021–2032)
 Figure 43. Israel Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. UAE Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Takeda Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 47. Johnson & Johnson Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 48. Novartis Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 49. Eli Lilly Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 50. Tris Pharma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 51. Neos Therapeutics Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 52. Mallinckrodt Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 53. Amneal Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 54. Noven Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 55. Purdue Parma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 56. Zhengdafenhai Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 57. Highland Therapeutics Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 58. Jubilant Life Sciences Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 59. Medice Arzneimittel Putter Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 60. Lannett Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Business (2021–2026)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Attention Deficit Hyperactivity Syndrome Treatment Market Research Report 2025
Attention Deficit Hyperactivity Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Attention deficit Hyperactivity Disorder ADHD Therapeutics Market Research Report 2024
ADHD Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Children Attention Deficit and Hyperactivity Disorder Market Research Report 2025
Global Attention Deficit and Hyperactivity Disorder Market Research Report 2025
Global Children ADHD Treatment Market Research Report 2024
Global Adult Attention Deficit and Hyperactivity Disorder Market Research Report 2025
Attention Deficit Hyperactivity Disorder ADHD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
ADHD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ADHD Drug Treatment Market Research Report 2024
Global Attention Deficit Hyperactivity Disorder Treatment Market Research Report 2024
Global ADHD Medications Market Insights Forecast to 2030
Global Attention Deficit Hyperactivity Disorder ADHD Medications Market Research Report 2024
Global ADHD Medication Market Research Report 2025
Global Pediatric ADHD Drugs Market Research Report 2025
Global ADHD Management Software Market Research Report 2024
Global Adult ADHD Treatment Market Research Report 2024
Global ADHD Apps Market Research Report 2024
Global Anti Adhd Supplements Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions